These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29846536)

  • 1. Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa.
    Deng C; Huang B; Wang Q; Wu W; Zheng S; Zhang H; Li D; Feng D; Li G; Xue L; Yang T; Tuo F; Mohadji F; Su XZ; Xu Q; Wu Z; Lin L; Zhou J; Yan H; Bacar A; Said Abdallah K; Kéké RA; Msa Mliva A; Mohamed M; Wang X; Huang S; Oithik F; Li XB; Lu F; Fay MP; Liu XH; Wellems TE; Song J
    Clin Infect Dis; 2018 Nov; 67(11):1670-1676. PubMed ID: 29846536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria Control by Mass Drug Administration With Artemisinin Plus Piperaquine on Grande Comore Island, Union of Comoros.
    Deng C; Wu W; Yuan Y; Li G; Zhang H; Zheng S; Li M; Tan R; Wang Y; Nadia J; Feng D; Li D; Wu Z; Xu Q; Li C; Wang Z; Liang Y; Doehl JSP; Su X; Bacar A; Said Abdallah K; Mohamed H; Msa Mliva A; Wellems TE; Song J
    Open Forum Infect Dis; 2023 Mar; 10(3):ofad076. PubMed ID: 36910690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine.
    Song J; Socheat D; Tan B; Dara P; Deng C; Sokunthea S; Seila S; Ou F; Jian H; Li G
    Malar J; 2010 Feb; 9():57. PubMed ID: 20175930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria: a cluster-randomised trial.
    McLean ARD; Indrasuta C; Khant ZS; Phyo AK; Maung SM; Heaton J; Aung H; Aung Y; Soe K; Swe MMM; von Seidlein L; Tun NN; Tun KM; Day NPJ; Ashley EA; Hlaing T; Kyaw TT; Dondorp AM; Imwong M; White NJ; Smithuis FM
    Lancet Infect Dis; 2021 Nov; 21(11):1579-1589. PubMed ID: 34147154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos.
    Pongvongsa T; Phommasone K; Adhikari B; Henriques G; Chotivanich K; Hanboonkunupakarn B; Mukaka M; Peerawaranun P; von Seidlein L; Day NPJ; White NJ; Dondorp AM; Imwong M; Newton PN; Singhasivanon P; Mayxay M; Pukrittayakamee S
    Malar J; 2018 Nov; 17(1):405. PubMed ID: 30390647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
    Phommasone K; van Leth F; Peto TJ; Landier J; Nguyen TN; Tripura R; Pongvongsa T; Lwin KM; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Nguon C; Davoeung C; Rekol H; Adhikari B; Promnarate C; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Cheah PY; Dhorda M; Imwong M; Mukaka M; Peerawaranun P; Pukrittayakamee S; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Cobelens F; Dondorp AM; White NJ; von Seidlein L
    PLoS One; 2020; 15(2):e0228190. PubMed ID: 32023293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial.
    Sutanto I; Suprijanto S; Kosasih A; Dahlan MS; Syafruddin D; Kusriastuti R; Hawley WA; Lobo NF; Ter Kuile FO
    Clin Infect Dis; 2013 Mar; 56(5):685-93. PubMed ID: 23175563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Controlled Trial of Mass Drug Administration to Interrupt Transmission of Multidrug-Resistant Falciparum Malaria in Cambodian Villages.
    Tripura R; Peto TJ; Chea N; Chan D; Mukaka M; Sirithiranont P; Dhorda M; Promnarate C; Imwong M; von Seidlein L; Duanguppama J; Patumrat K; Huy R; Grobusch MP; Day NPJ; White NJ; Dondorp AM
    Clin Infect Dis; 2018 Aug; 67(6):817-826. PubMed ID: 29522113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.
    Gerardin J; Eckhoff P; Wenger EA
    BMC Infect Dis; 2015 Mar; 15():144. PubMed ID: 25887935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Malaria in the Comoros Archipelago in 2015: status after 15 years of fight].
    Toyb M; Ouledi A; Gaüzère BA; Aubry P
    Bull Soc Pathol Exot; 2016 May; 109(2):107-13. PubMed ID: 27160218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Mass Drug Administration with Dihydroartemisinin-Piperaquine and
    Finn TP; Porter TR; Moonga H; Silumbe K; Daniels RF; Volkman SK; Yukich JO; Keating J; Bennett A; Steketee RW; Miller JM; Eisele TP
    Am J Trop Med Hyg; 2020 Aug; 103(2_Suppl):37-45. PubMed ID: 32618267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.
    Maude RJ; Socheat D; Nguon C; Saroth P; Dara P; Li G; Song J; Yeung S; Dondorp AM; Day NP; White NJ; White LJ
    PLoS One; 2012; 7(5):e37166. PubMed ID: 22662135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primaquine to prevent transmission of falciparum malaria.
    White NJ
    Lancet Infect Dis; 2013 Feb; 13(2):175-81. PubMed ID: 23182932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.
    Douglas NM; Poespoprodjo JR; Patriani D; Malloy MJ; Kenangalem E; Sugiarto P; Simpson JA; Soenarto Y; Anstey NM; Price RN
    PLoS Med; 2017 Aug; 14(8):e1002379. PubMed ID: 28850568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial.
    von Seidlein L; Peto TJ; Landier J; Nguyen TN; Tripura R; Phommasone K; Pongvongsa T; Lwin KM; Keereecharoen L; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Corbel V; Tuong-Vy N; Phuc-Nhi TL; Son DH; Huong-Thu PN; Tuyen NTK; Tien NT; Dong LT; Hue DV; Quang HH; Nguon C; Davoeung C; Rekol H; Adhikari B; Henriques G; Phongmany P; Suangkanarat P; Jeeyapant A; Vihokhern B; van der Pluijm RW; Lubell Y; White LJ; Aguas R; Promnarate C; Sirithiranont P; Malleret B; Rénia L; Onsjö C; Chan XH; Chalk J; Miotto O; Patumrat K; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Kaehler N; Cheah PY; Pell C; Dhorda M; Imwong M; Snounou G; Mukaka M; Peerawaranun P; Lee SJ; Simpson JA; Pukrittayakamee S; Singhasivanon P; Grobusch MP; Cobelens F; Smithuis F; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Dondorp AM; White NJ
    PLoS Med; 2019 Feb; 16(2):e1002745. PubMed ID: 30768615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.